258 related articles for article (PubMed ID: 17621240)
1. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.
Lewden C; Chene G; Morlat P; Raffi F; Dupon M; Dellamonica P; Pellegrin JL; Katlama C; Dabis F; Leport C; ;
J Acquir Immune Defic Syndr; 2007 Sep; 46(1):72-7. PubMed ID: 17621240
[TBL] [Abstract][Full Text] [Related]
2. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)-Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study.
Grabar S; Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; Pradier C; Salmon D; Simon A; Pourcher V; Spano JP; Poizot-Martin I; Costagliola D
HIV Med; 2019 Mar; 20(3):222-229. PubMed ID: 30693646
[TBL] [Abstract][Full Text] [Related]
3. All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
; Lewden C; Bouteloup V; De Wit S; Sabin C; Mocroft A; Wasmuth JC; van Sighem A; Kirk O; Obel N; Panos G; Ghosn J; Dabis F; Mary-Krause M; Leport C; Perez-Hoyos S; Sobrino-Vegas P; Stephan C; Castagna A; Antinori A; d'Arminio Monforte A; Torti C; Mussini C; Isern V; Calmy A; Teira R; Egger M; Grarup J; Chêne G
Int J Epidemiol; 2012 Apr; 41(2):433-45. PubMed ID: 22493325
[TBL] [Abstract][Full Text] [Related]
4. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study.
Guiguet M; Boué F; Cadranel J; Lang JM; Rosenthal E; Costagliola D;
Lancet Oncol; 2009 Dec; 10(12):1152-9. PubMed ID: 19818686
[TBL] [Abstract][Full Text] [Related]
5. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study.
; Cain LE; Logan R; Robins JM; Sterne JA; Sabin C; Bansi L; Justice A; Goulet J; van Sighem A; de Wolf F; Bucher HC; von Wyl V; Esteve A; Casabona J; del Amo J; Moreno S; Seng R; Meyer L; Perez-Hoyos S; Muga R; Lodi S; Lanoy E; Costagliola D; Hernan MA
Ann Intern Med; 2011 Apr; 154(8):509-15. PubMed ID: 21502648
[TBL] [Abstract][Full Text] [Related]
6. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries.
; Zwahlen M; Harris R; May M; Hogg R; Costagliola D; de Wolf F; Gill J; Fätkenheuer G; Lewden C; Saag M; Staszewski S; d'Arminio Monforte A; Casabona J; Lampe F; Justice A; von Wyl V; Egger M
Int J Epidemiol; 2009 Dec; 38(6):1624-33. PubMed ID: 19820106
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA EP 11 study.
Lewden C; Raffi F; Cuzin L; Cailleton V; Vildé JL; Chêne G; Allavena C; Salamon R; Leport C
J Infect Dis; 2002 Sep; 186(5):710-4. PubMed ID: 12195361
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.
McManus H; O'Connor CC; Boyd M; Broom J; Russell D; Watson K; Roth N; Read PJ; Petoumenos K; Law MG;
PLoS One; 2012; 7(11):e48839. PubMed ID: 23144991
[TBL] [Abstract][Full Text] [Related]
9. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholié SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D;
N Engl J Med; 2020 Jun; 382(25):2397-2410. PubMed ID: 32558469
[TBL] [Abstract][Full Text] [Related]
10. Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018.
Choufany M; Weiss L; Makinson A; Roul H; Livrozet JM; Pourcher V; Melica G; Rioux C; Viard JP; Marshall E; Grabar S; Costagliola D
Clin Infect Dis; 2023 Apr; 76(8):1364-1371. PubMed ID: 36527700
[TBL] [Abstract][Full Text] [Related]
11. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Loutfy MR; Genebat M; Moore D; Raboud J; Chan K; Antoniou T; Milan D; Shen A; Klein MB; Cooper C; Machouf N; Rourke SB; Rachlis A; Tsoukas C; Montaner JS; Walmsley SL; Smieja M; Bayoumi A; Mills E; Hogg RS;
J Acquir Immune Defic Syndr; 2010 Dec; 55(4):451-9. PubMed ID: 21105259
[TBL] [Abstract][Full Text] [Related]
12. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
[TBL] [Abstract][Full Text] [Related]
13. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
Mocroft A; Staszewski S; Weber R; Gatell J; Rockstroh J; Gasiorowski J; Panos G; Monforte Ad; Rakhmanova A; Phillips AN; Lundgren JD;
Antivir Ther; 2007; 12(3):325-33. PubMed ID: 17591022
[TBL] [Abstract][Full Text] [Related]
14. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.
Mutwa PR; Boer KR; Asiimwe-Kateera B; Tuyishimire D; Muganga N; Lange JM; van de Wijgert J; Asiimwe A; Reiss P; Geelen SP
PLoS One; 2014; 9(11):e111948. PubMed ID: 25365302
[TBL] [Abstract][Full Text] [Related]
16. Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
Badje A; Moh R; Gabillard D; Guéhi C; Kabran M; Ntakpé JB; Carrou JL; Kouame GM; Ouattara E; Messou E; Anzian A; Minga A; Gnokoro J; Gouesse P; Emieme A; Toni TD; Rabe C; Sidibé B; Nzunetu G; Dohoun L; Yao A; Kamagate S; Amon S; Kouame AB; Koua A; Kouamé E; Daligou M; Hawerlander D; Ackoundzé S; Koule S; Séri J; Ani A; Dembélé F; Koné F; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatunde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Karcher S; Rouzioux C; Kouame A; Assi R; Bakayoko A; Domoua SK; Deschamps N; Aka K; N'Dri-Yoman T; Salamon R; Journot V; Ahibo H; Ouassa T; Menan H; Inwoley A; Danel C; Eholié SP; Anglaret X;
Lancet Glob Health; 2017 Nov; 5(11):e1080-e1089. PubMed ID: 29025631
[TBL] [Abstract][Full Text] [Related]
17. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
[TBL] [Abstract][Full Text] [Related]
18. Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
May MT; Vehreschild JJ; Trickey A; Obel N; Reiss P; Bonnet F; Mary-Krause M; Samji H; Cavassini M; Gill MJ; Shepherd LC; Crane HM; d'Arminio Monforte A; Burkholder GA; Johnson MM; Sobrino-Vegas P; Domingo P; Zangerle R; Justice AC; Sterling TR; Miró JM; Sterne JAC; ; Boulle A; Stephan C; Miro JM; Cavassini M; Chêne G; Costagliola D; Dabis F; Monforte AD; Del Amo J; Van Sighem A; Fätkenheuer G; Gill J; Guest J; Haerry DH; Hogg R; Justice A; Shepherd L; Obel N; Crane H; Smith C; Reiss P; Saag M; Sterling T; Teira R; Williams M; Zangerle R; Sterne J; May M; Ingle S; Trickey A
Clin Infect Dis; 2016 Jun; 62(12):1571-1577. PubMed ID: 27025828
[TBL] [Abstract][Full Text] [Related]
19. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
[TBL] [Abstract][Full Text] [Related]
20. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
